Literature DB >> 6821800

Prognostic analysis of malignant pleural and peritoneal effusions.

S Yamada, T Takeda, K Matsumoto.   

Abstract

A total of 289 cases with malignant pleuroperitoneal effusions were reviewed, and their prognosis were analyzed in relation to the following factors: (1) chronologically divided series; (2) previous tumorectomy of the primary lesion; (3) presence or absence of other metastases; (4) site of effusion; (5) site of the primary lesion; (6) cytologic characteristics of effusion. Prognostic difference among each chronologically divided series was not noticed. Previous tumorectomy slightly improved the patient's survival. Other distant metastases had no significant influence on the prognosis. Pleural effusion gave better prognosis than peritoneal effusion. Patients of breast and lung cancer had longer expectancies, contrasting with those of gastric cancer. Formation of large clusters of cancer cells on smear preparations obtained from the tapped effusions was interpreted as a sign of good prognosis. Frequencies of cancer cell and lymphocyte occurrence on smear preparation did not have any relationship with the prognosis. The results showed that some factors of the patients at malignant effusion accumulating stage did contribute a great deal to their prognosis.

Entities:  

Mesh:

Year:  1983        PMID: 6821800     DOI: 10.1002/1097-0142(19830101)51:1<136::aid-cncr2820510127>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer.

Authors:  S Fujimoto; R D Shrestha; M Kokubun; K Kobayashi; S Kiuchi; C Konno; M Ohta; M Takahashi; Y Kitsukawa; M Mizutani
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

2.  Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.

Authors:  Lie-Jun Mei; Xiao-Jun Yang; Li Tang; Alaa Hammed Al-Shammaa Hassan; Yutaka Yonemura; Yan Li
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

3.  Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.

Authors:  S Koldsland; J L Svennevig; G Lehne; E Johnson
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

4.  Do concomitant ascites influence the effectiveness of palliative surgical management of pleural effusion in patients with malignancies?

Authors:  Jefferson Luiz Gross; Tatiana Guilherme Disanzio; Riad Naim Younes; Fabio José Haddad; Rodrigo Afonso da Silva; Antonio Bomfim Marçal Avertano
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

5.  Malignant ascites. Clinical and experimental observations.

Authors:  R N Garrison; L D Kaelin; R H Galloway; L S Heuser
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

6.  Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.

Authors:  Maneesh Kumarsing Beeharry; Zheng-Lun Zhu; Wen-Tao Liu; Xue-Xin Yao; Min Yan; Zheng-Gang Zhu
Journal:  BMC Cancer       Date:  2019-09-18       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.